Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Rossari Biotech Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 406 | 411 | 483 | 464 | 473 | 490 | 498 | 513 | 580 | 544 | 586 | 582 | 685 |
| Expenses + | 352 | 353 | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 | 608 |
| Operating Profit | 55 | 58 | 64 | 64 | 64 | 65 | 66 | 65 | 69 | 68 | 72 | 69 | 77 |
| OPM % | 13% | 14% | 13% | 14% | 13% | 13% | 13% | 13% | 12% | 12% | 12% | 12% | 11% |
| Other Income + | 3 | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 20 |
| Interest | 4 | 6 | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 |
| Depreciation | 16 | 14 | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 | 24 |
| Profit before tax | 37 | 39 | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 | 64 |
| Tax % | 22% | 26% | 26% | 28% | 25% | 26% | 27% | 25% | 28% | 27% | 26% | 23% | 28% |
| Net Profit + | 29 | 29 | 33 | 34 | 34 | 35 | 35 | 32 | 34 | 34 | 37 | 33 | 46 |
| EPS in Rs | 5.25 | 5.30 | 5.97 | 6.23 | 6.18 | 6.32 | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.30 |
Financials of Rossari Biotech Ltd
Annual income statement trend
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 516 | 600 | 709 | 1,483 | 1,656 | 1,831 | 2,080 | 2,396 |
| Expenses + | 438 | 495 | 586 | 1,299 | 1,433 | 1,581 | 1,815 | 2,110 |
| Operating Profit | 78 | 105 | 124 | 184 | 223 | 250 | 265 | 286 |
| OPM % | 15% | 17% | 17% | 12% | 13% | 14% | 13% | 12% |
| Other Income + | 1 | 4 | 9 | 13 | 6 | 8 | 5 | 24 |
| Interest | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 29 |
| Depreciation | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 79 |
| Profit before tax | 63 | 88 | 107 | 136 | 144 | 178 | 185 | 203 |
| Tax % | 28% | 26% | 25% | 28% | 26% | 26% | 26% | 26% |
| Net Profit + | 46 | 65 | 80 | 98 | 107 | 131 | 136 | 149 |
| EPS in Rs | 103.82 | 12.86 | 15.45 | 17.74 | 19.45 | 23.66 | 24.63 | 26.94 |
| Dividend Payout % | 0% | 4% | 3% | 3% | 3% | 2% | 2% | 2% |
Financials of Rossari Biotech Ltd
Capital structure and asset base
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 119 | 277 | 398 | 794 | 904 | 1,037 | 1,174 | 1,322 |
| Borrowings + | 8 | 67 | 0 | 8 | 74 | 119 | 218 | 436 |
| Other Liabilities + | 118 | 118 | 152 | 442 | 375 | 401 | 482 | 520 |
| Total Liabilities | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,289 |
| Fixed Assets + | 74 | 94 | 181 | 607 | 585 | 578 | 598 | 811 |
| CWIP | 3 | 22 | 0 | 1 | 16 | 47 | 140 | 173 |
| Investments | 0 | 18 | 0 | 36 | 51 | 63 | 84 | 35 |
| Other Assets + | 173 | 338 | 379 | 611 | 712 | 880 | 1,063 | 1,269 |
| Total Assets | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,289 |
Financials of Rossari Biotech Ltd
Operating, investing and financing cash movement
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 71 | 57 | 48 | 29 | 152 | 43 | 137 | 65 |
| Cash from Investing Activity + | -37 | -190 | -37 | -299 | -181 | -103 | -183 | -219 |
| Cash from Financing Activity + | -29 | 157 | -25 | 292 | 61 | 16 | 65 | 186 |
| Net Cash Flow | 5 | 23 | -14 | 22 | 32 | -44 | 19 | 32 |
| Free Cash Flow | 27 | -19 | -8 | -7 | 120 | -83 | -21 | -175 |
| CFO/OP | 118% | 74% | 64% | 43% | 89% | 39% | 74% | 47% |
Financials of Rossari Biotech Ltd
Working capital efficiency and return ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 57 | 74 | 75 | 78 | 85 | 83 | 85 |
| Inventory Days | 59 | 57 | 75 | 63 | 59 | 80 | 90 | 88 |
| Days Payable | 114 | 95 | 104 | 61 | 56 | 62 | 73 | 71 |
| Cash Conversion Cycle | 6 | 19 | 46 | 76 | 80 | 103 | 101 | 103 |
| Working Capital Days | 23 | 22 | 60 | 62 | 49 | 70 | 69 | 55 |
| ROCE % | 38% | 29% | 24% | 18% | 18% | 16% | 15% |